Therapeutic effects and safety of Rhodiol rose extract WSA® 1375 in subjects with life-stress symptoms - Results of an open-label study

Phytotherapy Research

Volumn 26, Issue 8, 2012, Pages 1220-1225

  Edwards, D ^a   Heufelder, A ^b   Zimmermann, A ^c  

^a White House Surgery   (United Kingdom)

^b Dr Willmar Schwabe GmbH and Co KG ^*  (Germany)

^c DR WILLMAR SCHWABE GMBH AND CO KG   (Germany)

Author keywords

life stress symptoms; Rhodiol rosea; therapeutic effects; WSA 1375

Indexed keywords

RHODIOLA ROSEA EXTRACT; RHODIOLA ROSEA WS 1375; UNCLASSIFIED DRUG;

ADULT; ANXIETY; ARTICLE; BREAST DISEASE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXHAUSTION; FATIGUE; FEMALE; FUNCTIONAL DISEASE; GASTROINTESTINAL DISEASE; HUMAN; INFECTION; INFESTATION; INJURY; KIDNEY DISEASE; LIFE STRESS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; METABOLIC DISORDER; MORNING DOSAGE; MULTICENTER STUDY; MULTIDIMENSIONAL FATIGUE INVENTORY 20; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; NUMBERS CONNECTING TEST; NUMERICAL ANALOGUE SCALES OF SUBJECTIVE STRESS SYMPTOMS; NUTRITIONAL DISORDER; OPEN STUDY; PERCEIVED STRESS QUESTIONNAIRE; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCTIVE TOXICITY; SHEEHAN DISABILITY SCALE; SKIN DISEASE; SYMPTOM; THORAX DISEASE; TREATMENT DURATION;

EID: 84864284045     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3712     Document Type: Article

References (21)

1. Bolshakov IV, Lozovskai EL, Sapezhinskii II,. 1998. (Antioxidant properties of series of extracts from medicinal plants). Biofizik 43: 186-188.
2. Brekhman II, Dardymov IV,. 1969. New substances of plant origin which increase nonspecific resistance. Annu Rev Pharmacol 9: 419-430.
3. Brown RP, Gerbarg PL, Ramazanov Z,. 2002. Rhodiol rosea. phytomedicinal overview. Herbal Gram 56: 40-52.
4. Darbinyan V, Aslanyan G, Amroyan E, Gabrielyan E, Malmstrom C, Panossian A,. 2007. Clinical trial of Rhodiol rose L. extract SHR-5 in the treatment of mild to moderate depression. Nord J Psychiatry 61: 343-348.
5. Darbinyan V, Kteyan A, Panossian A, Gabrielian E, Wikman G, Wagner H,. 2000. Rhodiol rose in stress induced fatigue- double blind cross-over study of standardized extract SHR-5 with repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine 7: 365-371.
6. De Bock K, Eijnde BO, Ramaekers M, Hespel P,. 2004. Acute Rhodiol rose intake can improve endurance exercise performance. Int J Sport Nutr Exerc Metab 14: 298-307.
7. Houtman I,. 2005. Work-related stress. European Working Conditions Observatory (EWCO), Dublin, Eurofound, 2005, available online at
8. Kelly GS,. 2001. Rhodiol rosea: possible plant adaptogen. Altern Med Rev 6: 293-302.
9. Levenstein S, Pranter C, Varvo V, et al,. 1993. Development of the Perceived Stress Questionnaire: new tool for psychosomatic research. J Psychosom Res 37: 19-32.
10. Milczarek M, Schneider E, Gonzalez ER,. 2009. OSH in Figures: Stress At Work-Facts and Figures. European Agency for Safety and Health at Work, Office for Official Publications of the European Communities: Luxembourg, 20-28.
11. Olsson EM, von Scheele B, Panossian AG,. 2009. randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR-5 of the roots of Rhodiol rose in the treatment of subjects with stress-related fatigue. Plant Med 75: 105-112.
12. Oswald WD, Roth E,. 1987. The Numbers Connecting Test, 2nd edn. Hogrefe Verlag: Göttingen, Toronto, Zürich.
13. Saratikov AS, Krasnov EA, Chnikin LA, et al,. 1968. Rhodioloside, new glycoside from Rhodiol rose and its pharmacological properties. Pharmazie 23: 392-395.
14. Sheehan DV, Harnett-Sheehan K, Raj BA,. 1996. The measurement of disability. Int Clin Psychopharmacol 11 (Suppl 3): 89-95.
15. Sheehan KH, Sheehan DV,. 2008. Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability Scale. Int Clin Psychopharmacol 23: 70-83.
16. Shevtsov VA, Zholus BI, Shervarly VI, et al,. 2003. randomized trial of two different doses of SHR-5 Rhodiol rose extract versus placebo and control of capacity for mental work. Phytomedicine 10: 95-105.
17. Smets EM, Garssen B, Bonke B, De Haes JC,. 1995. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39: 315-325.
18. Spasov AA, Wikman GK, Mandrikov VB, Mironov IA, Neumoin VV,. 2000. double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiol rose SHR-5 extract on the fatigue of students caused by stress during an examination period with repeated low-dose regimen. Phytomedicine 7: 85-89.
19. Stanchev SL, Mosharrof A,. 1987. Effect of the extract of Rhodiol rose L. on the content of the brain biogenic monoamines. Compt Rend Acad Bulg Sci 40: 85-87.
20. Steyer R, Schwenkmezger P, Notz P, Eid M,. 1997. Multidimensional Mood Questionnaire. Hogrefe Verlag: Göttingen, Bern, Toronto, Seattle.
21. Thomas RM, Hotsenpiller G, Peterson DA,. 2007. Acute psychosocial stress reduces cell survival in adult hippocampal neurogenesis without altering proliferation. J Neurosci 27: 2734-2743.